Log In
Print this Print this

Enoxaparin Sodium Injection, enoxaparin (formerly M-enoxaparin)

  Manage Alerts
Collapse Summary General Information
Company Momenta Pharmaceuticals Inc.
DescriptionLow molecular weight heparin
Molecular Target Factor Xa ; Thrombin (Factor IIa) (F2)
Mechanism of ActionAnti-thrombotic/thrombolytic
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentMarketed
Standard IndicationDeep vein thrombosis (DVT)
Indication DetailsTreat and prevent deep vein thrombosis (DVT) and treat acute coronary syndrome (ACS)
Regulatory Designation
PartnerNovartis AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today